子供向けに販売される化粧品の皮膚学的安全性:セフォラキッズ現象の洞察
Journal of drugs in dermatology : JDD
|September 5, 2025
まとめ
"セフォラ・キッズ"のトレンドでは 子供はレチノールや酸などの 成人のスキンケアを使用しています これらの製品は若い皮膚に対する安全性データがないため,刺激や敏感性の危険性があります.
科学分野:
- 小児皮膚科
- 化粧品科学
- 皮膚学的安全性
背景:
- "セフォラ・キッズ"というトレンドは 大人向けの美容製品を使用する子供や青少年を対象としています
- 小児の皮膚に対するこれらの製品の安全性と有効性については懸念があります.
- レチノール,脱皮酸 (AHA/BHA),ビタミンCなどの重要な成分が一般的です.
研究 の 目的:
- 子供が使用する製品の主要成分の皮膚学的影響を検討する.
- 子どもの皮膚ケアにおけるレチノール,AHA,BHA,ビタミンCの安全性と有効性を評価する.
- 若い人でのこれらの有効成分の無監督使用に関連するリスクを強調する.
主な方法:
- 小児の皮膚ケアと有効成分に関する最新の科学出版物の文献レビュー.
- 食品医薬品局のガイドラインと子供に対する成分の安全性に関する既存の研究を分析した.
- 乳児群におけるレチノール,脱皮酸,ビタミンCに関連する潜在的な有害作用の検討.
主要な成果:
- レチノール,AHA,BHA,およびビタミンCの小児使用の安全性および有効性に関する研究は限られている.
- 現行のFDAのガイドラインは,子供向けのこれらの成分を広範囲にカバーしていません.
- 潜在的リスクには,皮膚の赤み,刺激,日光に対する過敏性,皮膚炎が含まれます.
結論:
- 皮膚ケア用活性剤の無監督使用は子供に危険をもたらす.
- 小児用皮膚ケアの安全性プロファイルを確立するには,さらなる研究が不可欠です.
- 医療従事者や消費者は 子どものための より安全なスキンケアを 促進することができます
さらに関連する動画
10:13Eye Irritation Test EIT for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial RhCE Tissue Model
Published on: August 23, 2015
39.8K
21:16An In Vitro Skin Irritation Test SIT using the EpiDerm Reconstructed Human Epidermal RHE Model
Published on: July 13, 2009
68.8K
関連する概念動画
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
164
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
164
Pharmacokinetics in Pediatric Patients: Drug Distribution
189
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
189
Drug Dosing: Infants and Children
171
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
171
Pharmacokinetics in Pediatric Patients: Drug Metabolism
123
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
123
Pharmacokinetics in Pediatric Patients: Drug Excretion
147
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147
Drug Regulation
2.6K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K
